- We will send in 10–14 business days.
/images/books/2816159/9780128030141.jpg)
- Publisher: Academic Press
- ISBN-10: 0128030143
- ISBN-13: 9780128030141
- Format: 15.8 x 23.1 x 3.6 cm, hardcover
- Language: English
- SAVE -10% with code: EXTRA
Biomarkers of Kidney Disease (e-book) (used book) | bookbook.eu
Reviews
Description
Biomarkers of Kidney Disease, Second Edition, focuses on the basic and clinical research of biomarkers in common kidney diseases, detailing the characteristics of an ideal biomarker. The latest techniques for biomarker detection, including metabolomics and proteomics are covered in the book.
This comprehensive book details the latest advances made in the field of biomarker research and development in kidney diseases. The book is an ideal companion for those interested in biomarker research and development, proteomics and metabolomics, kidney diseases, statistical analysis, transplantation, and preeclampsia. New chapters include biomarkers of cardiovascular disease in patients with CKD, biomarkers of Polycystic Kidney Disease, and biomarkers and the role of nanomedicine.
EXTRA 10 % discount with code: EXTRA
The promotion ends in 16d.23:15:14
The discount code is valid when purchasing from 10 €. Discounts do not stack.
- Publisher: Academic Press
- ISBN-10: 0128030143
- ISBN-13: 9780128030141
- Format: 15.8 x 23.1 x 3.6 cm, hardcover
- Language: English English
Biomarkers of Kidney Disease, Second Edition, focuses on the basic and clinical research of biomarkers in common kidney diseases, detailing the characteristics of an ideal biomarker. The latest techniques for biomarker detection, including metabolomics and proteomics are covered in the book.
This comprehensive book details the latest advances made in the field of biomarker research and development in kidney diseases. The book is an ideal companion for those interested in biomarker research and development, proteomics and metabolomics, kidney diseases, statistical analysis, transplantation, and preeclampsia. New chapters include biomarkers of cardiovascular disease in patients with CKD, biomarkers of Polycystic Kidney Disease, and biomarkers and the role of nanomedicine.
Reviews